Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Saam Dilmaghani"'
Publikováno v:
Pharmacogenomics. 24:283-295
Aim: To analyze roles of single nucleotide variants (SNVs) on weight loss with US FDA-approved medications. Materials & methods: We searched the literature up until November 2022. Preferred Reporting Items for Systematic reviews and Meta-Analyses gui
Autor:
Wassel Sannaa, Saam Dilmaghani, Joelle BouSaba, Daniel Maselli, Jessica Atieh, Deborah Eckert, Ann L. Taylor, W. Scott Harmsen, Andres Acosta, Michael Camilleri
Publikováno v:
Diabetes, Obesity and Metabolism. 25:377-386
To identify patient factors, including gastrointestinal functions, that are predictive or associated with weight loss in response to once-daily 3 mg liraglutide administered subcutaneously (SQ) or placebo in obesity.One hundred and thirty-six obese a
Autor:
Joelle BouSaba, Monique Torres, Saam Dilmaghani, W. Scott Harmsen, Lei Ling, Michael Camilleri
Publikováno v:
Gastroenterology.
Autor:
Joelle BouSaba, Saam Dilmaghani, Ann Taylor, Irene Busciglio, Sanna McKinzie, Michael Camilleri
Publikováno v:
Gastro Hep Advances.
Publikováno v:
Mayo Clinic proceedings. 98(1)
Autor:
Michael Camilleri, Saam Dilmaghani
Publikováno v:
Pharmacology & Therapeutics. 245:108400
Autor:
Katie A. Dunleavy, Gabriela Piovezani Ramos, Saam Dilmaghani, Isabel Green, Priyal Fadadu, Adela Cope, Kristin Mara, Zaraq Khan, Wendaline VanBuren, Tatnai Burnett, Xiao Jing (Iris) Wang
Publikováno v:
American Journal of Gastroenterology. 117:e377-e378
Autor:
Michael Camilleri, Saam Dilmaghani
Publikováno v:
Gastroenterology. 163(4)
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
The authors performed a systematic review of epidemiologic data to understand the prevalence, incidence, etiologies, and hospitalizations related to gastroparesis (GP).Studies of the epidemiology of GP published in all languages, years, and countries
Publikováno v:
Gut. :gutjnl-2022